EP2201945B1
(en)
*
|
1997-11-21 |
2013-03-06 |
Purdue Neuroscience Company |
Use of substituted 2-aminoacetamides for treating or ameliorating anxiety
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
CA2755452C
(en)
|
1998-02-02 |
2013-09-10 |
Trustees Of Tufts College |
Method of regulating glucose metabolism, and reagents related thereto
|
AU2007202745B2
(en)
*
|
1998-02-02 |
2010-11-18 |
1149336 Ontario, Inc. |
Method of regulating glucose metabolism, and reagents related thereto
|
DE19823831A1
(de)
*
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
DE19834591A1
(de)
*
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
CO5150173A1
(es)
*
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
US6281211B1
(en)
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
AU3960400A
(en)
*
|
1999-03-05 |
2000-09-28 |
Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. |
Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv
|
GB9906714D0
(en)
*
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for improving fertility
|
GB9906715D0
(en)
*
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for promoting growth
|
US6110949A
(en)
*
|
1999-06-24 |
2000-08-29 |
Novartis Ag |
N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
US6617340B1
(en)
|
1999-07-29 |
2003-09-09 |
Novartis Ag |
N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
US6211384B1
(en)
|
1999-08-30 |
2001-04-03 |
Novartis Pharmaceuticals Corp. |
Methods for the acylation of amine compounds
|
GB9925264D0
(en)
*
|
1999-10-26 |
1999-12-29 |
Zeneca Ltd |
Chemical compounds
|
CA2390231A1
(en)
*
|
1999-11-12 |
2001-05-17 |
Paul Jackson |
Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
|
GB9928330D0
(en)
*
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
IL150204A0
(en)
*
|
1999-12-23 |
2002-12-01 |
Novartis Ag |
Use of hypoglycemic agent for treating impaired glucose metabolism
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
US20080076811A1
(en)
*
|
2000-01-21 |
2008-03-27 |
Bork Balkan |
Combinations comprising depeptidypeptidase-iv inhibitors and antidiabetic agents
|
US20030139434A1
(en)
|
2000-01-21 |
2003-07-24 |
Bork Balkan |
Combinations comprising dipeptidylpeptidase-iv inhibitor
|
AU2001228309A1
(en)
*
|
2000-01-24 |
2001-08-07 |
Novo-Nordisk A/S |
N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
|
EP1259246A2
(en)
*
|
2000-02-25 |
2002-11-27 |
Novo Nordisk A/S |
Use of dpp-iv inhibitors for the treatment of diabetes
|
US7064145B2
(en)
*
|
2000-02-25 |
2006-06-20 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
US6395767B2
(en)
*
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
JP2003528135A
(ja)
*
|
2000-03-31 |
2003-09-24 |
プロバイオドラッグ アーゲー |
糖尿病のランゲルハンス島シグナリングの改善方法及びその防止方法
|
GB0010188D0
(en)
*
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
GB0010183D0
(en)
*
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
TW583185B
(en)
*
|
2000-06-13 |
2004-04-11 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
AU2001268958B2
(en)
|
2000-07-04 |
2006-03-09 |
Novo Nordisk A/S |
Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv
|
EP1299362A4
(en)
*
|
2000-07-05 |
2004-11-03 |
Synaptic Pharma Corp |
SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
|
JP4101053B2
(ja)
*
|
2000-08-10 |
2008-06-11 |
田辺三菱製薬株式会社 |
プロリン誘導体及びその医薬用途
|
PE20020617A1
(es)
|
2000-08-22 |
2002-08-05 |
Novartis Ag |
Composicion que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina o un sensibilizante a la insulina
|
BR0114436A
(pt)
|
2000-10-06 |
2003-07-01 |
Tanabe Seiyaku Co |
Composto com anel de cinco elementos contendo nitrogênio alifático
|
EP1891948A1
(en)
|
2000-10-27 |
2008-02-27 |
Probiodrug AG |
Treatment of neurological and neuropsychological disorders
|
US7132104B1
(en)
|
2000-10-27 |
2006-11-07 |
Probiodrug Ag |
Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders
|
UA74023C2
(en)
*
|
2000-11-10 |
2005-10-17 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
TWI243162B
(en)
*
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
WO2002051836A1
(fr)
*
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Inhibiteur de dipeptidyl peptidase iv
|
DE10100053A1
(de)
*
|
2001-01-02 |
2002-08-22 |
Keyneurotek Ag I G |
Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
|
WO2002067918A1
(fr)
*
|
2001-02-27 |
2002-09-06 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de diallylmethylamine
|
JP2004525929A
(ja)
|
2001-03-27 |
2004-08-26 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病の治療または予防用のジペプチジルペプチダーゼ阻害薬
|
FR2822826B1
(fr)
*
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
US6890905B2
(en)
|
2001-04-02 |
2005-05-10 |
Prosidion Limited |
Methods for improving islet signaling in diabetes mellitus and for its prevention
|
DE60209348T2
(de)
|
2001-06-20 |
2006-10-12 |
Merck & Co., Inc. |
Dipeptidylpeptidase-hemmer zur behandlung von diabetes
|
US7098239B2
(en)
|
2001-06-20 |
2006-08-29 |
Merck & Co., Inc |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
DE60235212D1
(de)
|
2001-06-27 |
2010-03-11 |
Smithkline Beecham Corp |
Fluoropyrrolidine als Dipeptidylpeptidasehemmer
|
DE60223920T2
(de)
|
2001-06-27 |
2008-11-13 |
Smithkline Beecham Corp. |
Pyrrolidine als dipeptidyl-peptidase-inhibitoren
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
ATE370943T1
(de)
|
2001-06-27 |
2007-09-15 |
Smithkline Beecham Corp |
Fluoropyrrolidine als dipeptidyl-peptidase inhibitoren
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
US8084447B2
(en)
|
2001-09-03 |
2011-12-27 |
Newron Pharmaceuticals S.P.A. |
Pharmaceutical composition comprising gabapentin or an analogue thereof and an α-aminoamide and its analgesic use
|
US6844316B2
(en)
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
WO2003024942A1
(fr)
|
2001-09-14 |
2003-03-27 |
Mitsubishi Pharma Corporation |
Derive thiazolidine et son utilisation medicamenteuse
|
US6861440B2
(en)
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
AU2002357767C1
(en)
|
2001-11-26 |
2009-03-19 |
Trustees Of Tufts College |
Peptidomimetic inhibitors of post-proline cleaving enzymes
|
JP2005511636A
(ja)
|
2001-11-26 |
2005-04-28 |
トラスティーズ オブ タフツ カレッジ |
自己免疫疾患の治療方法及びそれに関する試薬
|
GB0129988D0
(en)
*
|
2001-12-14 |
2002-02-06 |
Ferring Bv |
Imidazolidineacetic acid derivatives
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
DE60302336T2
(de)
|
2002-02-13 |
2006-08-03 |
F. Hoffmann-La Roche Ag |
Neue pyridin- und quinolin-derivate
|
MXPA04007744A
(es)
|
2002-02-13 |
2004-10-15 |
Hoffmann La Roche |
Nuevos derivados de piridina y pirimidina.
|
CN1622941A
(zh)
|
2002-02-28 |
2005-06-01 |
普罗西迪恩有限公司 |
基于谷氨酰胺酰基的dpiv抑制剂
|
HUP0200849A2
(hu)
*
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
JPWO2003095425A1
(ja)
*
|
2002-05-09 |
2005-09-15 |
大正製薬株式会社 |
シアノピロリジン誘導体
|
US6710040B1
(en)
|
2002-06-04 |
2004-03-23 |
Pfizer Inc. |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
|
HUP0202001A2
(hu)
*
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
JPWO2004007446A1
(ja)
*
|
2002-07-10 |
2005-11-10 |
アステラス製薬株式会社 |
新規なアゼチジン誘導体又はその塩
|
AU2003251869A1
(en)
|
2002-07-15 |
2004-02-02 |
Merck & Co., Inc. |
Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
|
TW200401635A
(en)
|
2002-07-23 |
2004-02-01 |
Yamanouchi Pharma Co Ltd |
2-Cyano-4-fluoropyrrolidine derivative or salt thereof
|
JP4542757B2
(ja)
*
|
2002-08-08 |
2010-09-15 |
武田薬品工業株式会社 |
縮合複素環化合物
|
AU2003254852A1
(en)
|
2002-08-08 |
2004-02-25 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds as peptidase inhibitors
|
PT1528931E
(pt)
*
|
2002-08-09 |
2008-08-13 |
Prosidion Ltd |
Inibidores da dipeptidilpeptidase iv para a diminuição da taxa de aumento de peso crónico
|
EA007613B1
(ru)
*
|
2002-08-29 |
2006-12-29 |
Тайсо Фармасьютикал Ко., Лтд. |
Бензолсульфонатная соль (2s,4s)-1-циано-4-фтор-1-[(2-гидрокси-1,1-диметил)этиламино]ацетилпирролидина
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
DE60315687T2
(de)
|
2002-10-07 |
2008-06-05 |
Merck & Co., Inc. |
Antidiabetische heterocyclische beta-aminoverbindungen als inhibitoren von dipeptidylpeptidase
|
EP1556362B1
(en)
|
2002-10-18 |
2008-03-26 |
Merck & Co., Inc. |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
AU2003290577B2
(en)
|
2002-11-07 |
2008-12-11 |
Merck Sharp & Dohme Corp. |
Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
GEP20084540B
(en)
|
2003-01-14 |
2008-11-25 |
Arena Pharm Inc |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
EP1438956A1
(en)
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful as antimigraine agents
|
AU2004206812A1
(en)
|
2003-01-17 |
2004-08-05 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
WO2004067509A1
(ja)
|
2003-01-31 |
2004-08-12 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
ジペプチジルペプチダーゼivを阻害する化合物
|
JP2006516573A
(ja)
|
2003-01-31 |
2006-07-06 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての3−アミノ−4−フェニルブタン酸誘導体
|
DE10308351A1
(de)
|
2003-02-27 |
2004-11-25 |
Aventis Pharma Deutschland Gmbh |
1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE10308355A1
(de)
|
2003-02-27 |
2004-12-23 |
Aventis Pharma Deutschland Gmbh |
Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
US7148246B2
(en)
|
2003-02-27 |
2006-12-12 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
|
DE10308352A1
(de)
|
2003-02-27 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
DE10308353A1
(de)
|
2003-02-27 |
2004-12-02 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
WO2004089362A1
(en)
*
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
2-cyanopyrroles and their analogues as ddp-iv inhibitors
|
PE20050021A1
(es)
|
2003-04-16 |
2005-03-15 |
Novartis Ag |
Procedimiento para la preparacion de 2-cianopirrolidina n-sustituida
|
GB0308854D0
(en)
*
|
2003-04-16 |
2003-05-21 |
Novartis Ag |
Organic compounds
|
ATE464889T1
(de)
|
2003-05-05 |
2010-05-15 |
Probiodrug Ag |
Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen
|
DE202004021723U1
(de)
|
2003-05-05 |
2010-07-15 |
Probiodrug Ag |
Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen
|
ATE462432T1
(de)
|
2003-05-05 |
2010-04-15 |
Probiodrug Ag |
Glutaminylcyclase-hemmer
|
ATE447574T1
(de)
|
2003-05-14 |
2009-11-15 |
Merck & Co Inc |
3-amino-4-phenylbutansäurederivate als dipeptidylpeptidase-hemmer zur behandlung oder vorbeugung von diabetes
|
KR20060009933A
(ko)
*
|
2003-05-15 |
2006-02-01 |
다이쇼 세이야꾸 가부시끼가이샤 |
시아노플루오로피롤리딘 유도체
|
ATE463492T1
(de)
|
2003-06-06 |
2010-04-15 |
Merck Sharp & Dohme |
Kondensierte indole als dipeptidyl-peptidase- hemmer zur behandlung oder prävention von diabetes
|
CA2527806A1
(en)
|
2003-06-17 |
2004-12-29 |
Merck & Co., Inc. |
Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
CA2528784C
(en)
|
2003-06-20 |
2012-02-21 |
Markus Boehringer |
Hexahydropyridoisoquinolines as dpp-iv inhibitors
|
DK1638970T3
(da)
|
2003-06-20 |
2011-01-03 |
Hoffmann La Roche |
Pyrid (2, 1-A)-isoquinolinderivater som DPP-IV-inhibitorer
|
CN1882551A
(zh)
|
2003-07-31 |
2006-12-20 |
麦克公司 |
用作用于治疗或预防糖尿病的二肽基肽酶-iv酶抑制剂的六氢二氮杂吖庚因酮
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
WO2005033099A2
(en)
*
|
2003-10-03 |
2005-04-14 |
Glenmark Pharmaceuticals Ltd. |
Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
|
EP1675578B9
(en)
|
2003-10-15 |
2014-06-25 |
Probiodrug AG |
Inhibitors of glutaminyl and glutamate cyclases for the treatment of the neurodegenerative diseases fbd and fdd
|
NZ546887A
(en)
|
2003-11-03 |
2009-04-30 |
Probiodrug Ag |
Combinations useful for the treatment of neuronal disorders
|
SI1689757T1
(sl)
|
2003-11-12 |
2015-01-30 |
Sino-Med International Alliance, Inc. |
Heterociklične spojine boronske kisline
|
US7576121B2
(en)
|
2003-11-12 |
2009-08-18 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
US7767828B2
(en)
|
2003-11-12 |
2010-08-03 |
Phenomix Corporation |
Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
US7317109B2
(en)
|
2003-11-12 |
2008-01-08 |
Phenomix Corporation |
Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
BRPI0416628A
(pt)
*
|
2003-11-17 |
2007-01-16 |
Novartis Ag |
uso de compostos orgánicos
|
RU2766487C2
(ru)
|
2004-01-20 |
2022-03-15 |
Новартис Аг |
Композиция и способ прямого прессования
|
US7241787B2
(en)
|
2004-01-25 |
2007-07-10 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
|
US7230002B2
(en)
|
2004-02-03 |
2007-06-12 |
Glenmark Pharmaceuticals Ltd. |
Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
|
PT1712547E
(pt)
|
2004-02-05 |
2012-03-06 |
Kyorin Seiyaku Kk |
Derivado de éster bicíclico
|
AU2005210004B2
(en)
|
2004-02-05 |
2010-10-28 |
Probiodrug Ag |
Novel inhibitors of glutaminyl cyclase
|
KR20060129021A
(ko)
*
|
2004-02-18 |
2006-12-14 |
교린 세이야꾸 가부시키 가이샤 |
비시클로아미드 유도체
|
AU2005215136A1
(en)
*
|
2004-02-20 |
2005-09-01 |
Novartis Ag |
DPP-IV inhibitors for treating neurodegeneration and cognitive disorders
|
JP4689599B2
(ja)
*
|
2004-02-27 |
2011-05-25 |
杏林製薬株式会社 |
ビシクロ誘導体
|
DE602004004631D1
(de)
|
2004-04-01 |
2007-03-22 |
Sanofi Aventis Deutschland |
Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika
|
AU2005241056A1
(en)
|
2004-05-04 |
2005-11-17 |
Merck & Co., Inc. |
1,2,4-oxadiazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
US7671073B2
(en)
|
2004-05-18 |
2010-03-02 |
Merck Sharp & Dohme Corp. |
Cyclohexylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
|
FR2870538B1
(fr)
*
|
2004-05-19 |
2006-07-14 |
Servier Lab |
Nouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
EP1598341A1
(en)
*
|
2004-05-21 |
2005-11-23 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
EP1604980A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
EP1604989A1
(en)
*
|
2004-06-08 |
2005-12-14 |
Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft |
DPP-IV inhibitors
|
US7786163B2
(en)
|
2004-07-12 |
2010-08-31 |
Forest Laboratories Holdings Limited (BM) |
Constrained cyano compounds
|
CN101087756B
(zh)
|
2004-07-23 |
2011-04-06 |
纽阿达有限责任公司 |
肽酶抑制剂
|
AR050615A1
(es)
|
2004-08-27 |
2006-11-08 |
Novartis Ag |
Composiciones farmaceuticas para la administracion oral
|
EA013463B1
(ru)
|
2004-10-12 |
2010-04-30 |
ГЛЕНМАРК ФАРМАСЬЮТИКАЛС Эс.Эй. |
Новые ингибиторы дипептидилпептидазы iv, содержащие их фармацевтические композиции, способ их получения и способ лечения с их применением
|
US7411093B2
(en)
|
2004-12-20 |
2008-08-12 |
Hoffman-La Roche Inc. |
Aminocycloalkanes as DPP-IV inhibitors
|
CN101090888A
(zh)
|
2004-12-20 |
2007-12-19 |
霍夫曼-拉罗奇有限公司 |
4-氨基哌啶衍生物
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
EA013119B1
(ru)
|
2005-02-18 |
2010-02-26 |
Мицубиси Танабе Фарма Корпорейшн |
Соль производного пролина, ее сольват и способ ее получения
|
WO2006100181A2
(en)
*
|
2005-03-22 |
2006-09-28 |
F. Hoffmann-La Roche Ag |
New salt and polymorphs of a dpp-iv inhibitor
|
US7825139B2
(en)
|
2005-05-25 |
2010-11-02 |
Forest Laboratories Holdings Limited (BM) |
Compounds and methods for selective inhibition of dipeptidyl peptidase-IV
|
DE102005026762A1
(de)
|
2005-06-09 |
2006-12-21 |
Sanofi-Aventis Deutschland Gmbh |
Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
ES2426345T3
(es)
|
2005-07-20 |
2013-10-22 |
Eli Lilly And Company |
Compuesto unidos en posición 1-amino
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
ME02005B
(me)
|
2005-09-14 |
2012-08-31 |
Takeda Pharmaceuticals Co |
Inhibitori dipeptidil peptidaze za lečenje dijabetesa
|
EP1924567B1
(en)
|
2005-09-16 |
2012-08-22 |
Takeda Pharmaceutical Company Limited |
Process for the preparation of pyrimidinedione derivatives
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
EP1995237A4
(en)
|
2006-03-08 |
2011-07-06 |
Kyorin Seiyaku Kk |
PROCESS FOR PREPARING AN AMINOACETYLPYRROLIDINCARBONITRILE DERIVATIVE AND PRODUCTION PRODUCT THEREOF
|
WO2007112347A1
(en)
|
2006-03-28 |
2007-10-04 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
DE602007012845D1
(de)
*
|
2006-04-03 |
2011-04-14 |
Matrix Lab Ltd |
Neue dipeptidylpeptidase-iv-inhibitoren und verfahren zur ihrer herstellung und pharmazeutische zusammensetzung, die diese enthalten
|
CN101050194B
(zh)
*
|
2006-04-05 |
2013-08-21 |
上海恒瑞医药有限公司 |
双环辛烷类衍生物、其制备方法及其在医药上的用途
|
WO2007120689A2
(en)
|
2006-04-11 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
WO2007116092A1
(en)
|
2006-04-12 |
2007-10-18 |
Probiodrug Ag |
Enzyme inhibitors
|
EP2089383B1
(en)
|
2006-11-09 |
2015-09-16 |
Probiodrug AG |
3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
|
TW200838536A
(en)
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
JP5523107B2
(ja)
|
2006-11-30 |
2014-06-18 |
プロビオドルグ エージー |
グルタミニルシクラーゼの新規阻害剤
|
CN101230058A
(zh)
|
2007-01-23 |
2008-07-30 |
上海恒瑞医药有限公司 |
双环氮杂烷类衍生物、其制备方法及其在医药上的用途
|
WO2008114857A1
(ja)
|
2007-03-22 |
2008-09-25 |
Kyorin Pharmaceutical Co., Ltd. |
アミノアセチルピロリジンカルボニトリル誘導体の製造方法
|
JP5616630B2
(ja)
|
2007-04-03 |
2014-10-29 |
田辺三菱製薬株式会社 |
ジペプチジルペプチダーゼ4阻害化合物と甘味料との併用
|
US9656991B2
(en)
|
2007-04-18 |
2017-05-23 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
US8338450B2
(en)
|
2007-09-21 |
2012-12-25 |
Lupin Limited |
Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors
|
CN101468988A
(zh)
|
2007-12-26 |
2009-07-01 |
上海恒瑞医药有限公司 |
哌嗪类衍生物,其制备方法及其在医药上的应用
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
EP2246347B1
(en)
|
2008-01-23 |
2016-09-28 |
Shanghai Hengrui Pharmaceutical Co. Ltd. |
Dicycloazaalkane derivates, preparation processes and medical uses thereof
|
US8551524B2
(en)
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
EP2146210A1
(en)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
|
EP2322499A4
(en)
|
2008-08-07 |
2011-12-21 |
Kyorin Seiyaku Kk |
PROCESS FOR PRODUCING A BICYCLOÝ2.2.2¨OCTYLAMINE DERIVATIVE
|
CZ2008512A3
(cs)
|
2008-08-26 |
2010-03-10 |
Zentiva, A. S |
Zpusob prípravy vysoce cistého vildagliptinu
|
JO2870B1
(en)
|
2008-11-13 |
2015-03-15 |
ميرك شارب اند دوهم كورب |
Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes
|
TW201024283A
(en)
*
|
2008-12-01 |
2010-07-01 |
Targacept Inc |
Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine
|
WO2010079433A2
(en)
|
2009-01-07 |
2010-07-15 |
Glenmark Pharmaceuticals, S.A. |
Pharmaceutical composition that includes a dipeptidyl peptidase-iv inhibitor
|
WO2010079413A2
(en)
|
2009-01-09 |
2010-07-15 |
Orchid Research Laboratories Ltd. |
Dipeptidyl peptidase iv inhibitors
|
CN101824036A
(zh)
|
2009-03-05 |
2010-09-08 |
上海恒瑞医药有限公司 |
四氢咪唑并[1,5-a]吡嗪衍生物的盐,其制备方法及其在医药上的应用
|
KR20120003906A
(ko)
|
2009-03-27 |
2012-01-11 |
교린 세이야꾸 가부시키 가이샤 |
염기성 첨가제를 함유하는 매트릭스형 서방성 제제
|
AU2010247391A1
(en)
|
2009-05-15 |
2011-12-01 |
Novartis Ag |
Benzoxazolone derivatives as aldosterone synthase inhibitors
|
CN102803217B
(zh)
|
2009-05-15 |
2015-06-17 |
诺华股份有限公司 |
作为醛固酮合酶抑制剂的芳基吡啶
|
ES2582395T3
(es)
|
2009-05-28 |
2016-09-12 |
Novartis Ag |
Derivados aminobutíricos sustituidos como inhibidores de neprilisina
|
NZ596304A
(en)
|
2009-05-28 |
2014-01-31 |
Novartis Ag |
Substituted aminopropionic derivatives as neprilysin inhibitors
|
WO2010142985A1
(en)
*
|
2009-06-10 |
2010-12-16 |
Astrazeneca Ab |
Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
|
US8748457B2
(en)
|
2009-06-18 |
2014-06-10 |
Lupin Limited |
2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
IN2012DN00721A
(hu)
|
2009-09-02 |
2015-06-19 |
Merck Sharp & Dohme |
|
ES2548913T3
(es)
|
2009-09-11 |
2015-10-21 |
Probiodrug Ag |
Derivados heterocíclicos como inhibidores de glutaminil ciclasa
|
EA201200486A1
(ru)
|
2009-09-15 |
2012-08-30 |
Серулин Фарма Инк. |
Лечение онкологических заболеваний
|
US8519134B2
(en)
|
2009-11-17 |
2013-08-27 |
Novartis Ag |
Aryl-pyridine derivatives as aldosterone synthase inhibitors
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
BR112012012210B8
(pt)
|
2009-11-23 |
2021-05-25 |
Cerulean Pharma Inc |
conjugado de (cdp)-taxano de polímero contendo ciclodextrina, composição, composição farmacêutica, forma de dosagem, kit e uso de um conjugado de cdp-taxano
|
US8575160B2
(en)
|
2009-11-30 |
2013-11-05 |
Novartis Ag |
Imidazole derivatives as aldosterone synthase inhibitors
|
US20110178287A1
(en)
|
2010-01-19 |
2011-07-21 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
US8853212B2
(en)
|
2010-02-22 |
2014-10-07 |
Merck Sharp & Dohme Corp |
Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
|
EP2542549B1
(en)
|
2010-03-03 |
2016-05-11 |
Probiodrug AG |
Inhibitors of glutaminyl cyclase
|
EP2545047B9
(en)
|
2010-03-10 |
2015-06-10 |
Probiodrug AG |
Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
|
WO2011127051A1
(en)
|
2010-04-06 |
2011-10-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US8581001B2
(en)
|
2010-04-16 |
2013-11-12 |
Codman & Shurtleff |
Metformin-cysteine prodrug
|
JP5945532B2
(ja)
|
2010-04-21 |
2016-07-05 |
プロビオドルグ エージー |
グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体
|
US8980929B2
(en)
|
2010-05-21 |
2015-03-17 |
Merck Sharp & Dohme Corp. |
Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
|
PE20131371A1
(es)
|
2010-09-22 |
2013-11-25 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con este
|
WO2012049566A1
(en)
|
2010-10-14 |
2012-04-19 |
Japan Tobacco Inc. |
Combination therapy for use in treating diabetes
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
US8877815B2
(en)
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
WO2012123563A1
(en)
|
2011-03-16 |
2012-09-20 |
Probiodrug Ag |
Benz imidazole derivatives as inhibitors of glutaminyl cyclase
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145603A1
(en)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US20140051714A1
(en)
|
2011-04-22 |
2014-02-20 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012170702A1
(en)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US9051329B2
(en)
|
2011-07-05 |
2015-06-09 |
Merck Sharp & Dohme Corp. |
Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
|
WO2013055910A1
(en)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
US9115082B2
(en)
*
|
2012-01-18 |
2015-08-25 |
Catherine Yang |
Dipeptidyl-peptidase-IV inhibitors for treatment of type 2 diabetes complex with hypertension
|
WO2013122920A1
(en)
|
2012-02-17 |
2013-08-22 |
Merck Sharp & Dohme Corp. |
Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
CN103509023B
(zh)
|
2012-06-20 |
2014-08-27 |
成都苑东药业有限公司 |
黄嘌呤衍生物
|
US9567300B2
(en)
|
2012-06-25 |
2017-02-14 |
Sunshine Lake Pharma Co., Ltd. |
Hexahydropentaleno derivatives, preparation method and use in medicine thereof
|
WO2014018350A1
(en)
|
2012-07-23 |
2014-01-30 |
Merck Sharp & Dohme Corp. |
Treating diabetes with dipeptidyl peptidase-iv inhibitors
|
EA021236B1
(ru)
*
|
2012-10-03 |
2015-05-29 |
Дафот Энтерпраизес Лимитед |
Nα-АЦИЛЬНЫЕ ПРОИЗВОДНЫЕ АМИНОАЦИЛ-2-ЦИАНОПИРРОЛИДИНА - ИНГИБИТОРЫ ПРОЛИЛЭНДОПЕПТИДАЗЫ И ДИПЕПТИДИЛПЕПТИДАЗЫ-IV, ОБЛАДАЮЩИЕ ГИПОГЛИКЕМИЧЕСКИМ, ПРОТИВОГИПОКСИЧЕСКИМ, НЕЙРОПРОТЕКТОРНЫМ И УЛУЧШАЮЩИМ КОГНИТИВНЫЕ ФУНКЦИИ ДЕЙСТВИЕМ
|
TWI500613B
(zh)
|
2012-10-17 |
2015-09-21 |
Cadila Healthcare Ltd |
新穎之雜環化合物
|
WO2014074668A1
(en)
|
2012-11-08 |
2014-05-15 |
Arena Pharmaceuticals, Inc. |
Modulators of gpr119 and the treatment of disorders related thereto
|
UY35144A
(es)
|
2012-11-20 |
2014-06-30 |
Novartis Ag |
Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca
|
CN103922986B
(zh)
*
|
2013-01-16 |
2017-02-15 |
上海彩迩文生化科技有限公司 |
维大列汀及其类似物、中间体及其制备方法和应用
|
EP2956464B1
(en)
|
2013-02-14 |
2018-03-28 |
Novartis AG |
Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
|
UY35670A
(es)
|
2013-07-25 |
2015-02-27 |
Novartis Ag |
Polipéptidos cíclicos para el tratamiento de insuficiencia cardíaca
|
MX2016001021A
(es)
|
2013-07-25 |
2016-08-03 |
Novartis Ag |
Bioconjugados de polipeptidos de apelina sinteticos.
|
WO2015145467A1
(en)
*
|
2014-03-28 |
2015-10-01 |
Laurus Labs Private Limited |
An improved process for preparing vildagliptin
|
GB201415598D0
(en)
|
2014-09-03 |
2014-10-15 |
Univ Birmingham |
Elavated Itercranial Pressure Treatment
|
CN104557667A
(zh)
*
|
2014-12-12 |
2015-04-29 |
山东省药学科学院 |
2-氰基吡咯烷类化合物、制备方法及其应用
|
NZ734220A
(en)
|
2015-01-06 |
2022-01-28 |
Arena Pharm Inc |
Methods of treating conditions related to the s1p1 receptor
|
CN104529858A
(zh)
*
|
2015-01-13 |
2015-04-22 |
佛山市赛维斯医药科技有限公司 |
含卤代金刚烷和酰胺类衍生物、其制备方法和用途
|
CN104529856A
(zh)
*
|
2015-01-13 |
2015-04-22 |
佛山市赛维斯医药科技有限公司 |
一种硝基金刚烷酰胺衍生物、其制备方法和用途
|
US9931372B2
(en)
|
2015-01-23 |
2018-04-03 |
Novartis Ag |
Synthetic apelin fatty acid conjugates with improved half-life
|
SG11201707276PA
(en)
|
2015-03-09 |
2017-10-30 |
Intekrin Therapeutics Inc |
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
|
TWI682931B
(zh)
|
2015-05-29 |
2020-01-21 |
大陸商江蘇天士力帝益藥業有限公司 |
黃嘌呤衍生物、其藥物組成物、其製劑以及其用途
|
IL285890B
(en)
|
2015-06-22 |
2022-07-01 |
Arena Pharm Inc |
Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
|
JOP20190086A1
(ar)
|
2016-10-21 |
2019-04-18 |
Novartis Ag |
مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
|
WO2018162722A1
(en)
|
2017-03-09 |
2018-09-13 |
Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke |
Dpp-4 inhibitors for use in treating bone fractures
|
AU2018249822A1
(en)
|
2017-04-03 |
2019-10-31 |
Coherus Biosciences Inc. |
PPArgamma agonist for treatment of progressive supranuclear palsy
|
ES2733477T3
(es)
|
2017-07-04 |
2019-11-29 |
Fis Fabbrica Italiana Sintetici Spa |
Procedimiento eficaz para la preparación de sitagliptina a través de una preparación muy eficaz del intermedio ácido 2,4,5-trifluorofenilacético
|
DK3461819T3
(da)
|
2017-09-29 |
2020-08-10 |
Probiodrug Ag |
Inhibitorer af glutaminylcyklase
|
UY38072A
(es)
|
2018-02-07 |
2019-10-01 |
Novartis Ag |
Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
|
EP3524605B1
(en)
|
2018-02-13 |
2019-11-27 |
F.I.S.- Fabbrica Italiana Sintetici S.p.A. |
New efficient process for the preparation of sitagliptin
|
JP2022507958A
(ja)
|
2018-11-27 |
2022-01-18 |
ノバルティス アーゲー |
代謝障害の治療用のプロタンパク質転換酵素サブチリシン/ケキシン9型(pcsk9)阻害薬としての環状四量体化合物
|
UY38485A
(es)
|
2018-11-27 |
2020-06-30 |
Novartis Ag |
Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
|
JP2022509184A
(ja)
|
2018-11-27 |
2022-01-20 |
ノバルティス アーゲー |
代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン/ケキシン9型(pcsk9)阻害剤としての環状ペプチド
|
WO2022003405A1
(en)
*
|
2020-07-03 |
2022-01-06 |
Savoi Guilherme |
One-pot process to obtain a pyrrolidine-2-carbonitrile intermediate compound and industrial scale telescopic process to prepare (2s)-1-[n-(3-hydroxyadamantan-1-yl)glycyl]-2-pyrrolidinecarbonitrile (vildagliptin) using same
|
US20230285576A1
(en)
|
2020-08-05 |
2023-09-14 |
Ellipses Pharma Ltd |
Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor
|
TW202333563A
(zh)
|
2021-11-12 |
2023-09-01 |
瑞士商諾華公司 |
用於治療疾病或障礙之二胺基環戊基吡啶衍生物
|
AR127698A1
(es)
|
2021-11-23 |
2024-02-21 |
Novartis Ag |
Derivados de naftiridinona para el tratamiento de una enfermedad o un trastorno
|
CN115322129A
(zh)
*
|
2022-08-29 |
2022-11-11 |
湖北科技学院 |
双氰基吡咯烷类衍生物及其制备方法和应用
|